Castrate Refractory Metastatic Prostate Cancer (mCRPC)
1 clinical trials · Condition
◉ Watch Castrate Refractory Metastatic Prostate Cancer (mCRPC)
| Record | Firm | Date |
|---|---|---|
| A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T (NCT02232230) | GenesisCare USA | 2014-06-01 |
Track Castrate Refractory Metastatic Prostate Cancer (mCRPC) automatically
Every clearance here is in the API, with alerts when new ones post.